ARCHIVES

Individualized Cancer Vaccines Show 90% Survival at 6 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

Randomized Trial Finds Sunscreen Use Cuts Risk Of Developing Melanoma

December 31, 2010

M.D. Anderson Stops Establishing Satellite Clinics, Views Role as Working With All Texas Oncologists

November 22, 1996

Daniel Hayes Elected President of ASCO

December 12, 2014